Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Genitourinary Cancers
•
Medical Oncology
What is your protocol for intermittent ADT for prostate cancer?
Related Questions
What is the optimal approach to systemic therapy for metastatic squamous cell carcinoma of the bladder considering the approval of enfortumab vedotin plus pembrolizumab for metastatic urothelial carcinoma?
Would you give any adjuvant therapy (chemo, immunotherapy and/or radiation) to a patient with pure small cell cancer of the urinary bladder who received neoadjuvant cisplatin and etoposide but had pN+ and residual invasive disease on cystectomy?
Are there any scenarios in which you would consider use of PARPi in the upfront mCSPC setting rather than reserving for CRPC?
How do you differentiate between osseous metastases and Paget's disease on PSMA PET?
Is it safe to administer cabazitaxel to a patient with mCRPC who developed grade 3 pneumonitis from docetaxel?
What is the optimal approach for high risk prostate cancer patients who have been found to have positive nodes after surgery?
Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?
Why are patients getting enzalutamide s/p prostatectomy not candidates for salvage radiation therapy?
Would you use fezolinetant for hot flashes for men on ADT?
How would you approach treating a patient with prostate adenocarcinoma with urothelial features?
